Full-Time
Commercial Operations Manager
Sales Operations
Posted on 9/10/2025
Hinge Health
1,001-5,000 employees
Digital clinic delivering tech-enabled physical therapy
Compensation Overview
$115.2k - $172.8k/yr
San Francisco, CA, USA
Hybrid
Employees in hybrid roles are required to be in the office 3 days per week.
 Operations & Logistics (2) |
|---|
| , |
- 3–6 years of experience in Commercial Operations, Revenue Operations, or Sales Operations, preferably in a high-growth environment.
- Demonstrated ability to translate data into insights and influence decision-making.
- Proven success in process improvement and scaling operations.
- Highly organized, detail-oriented, and comfortable managing multiple priorities.
- Partner with Sales and Partnerships teams to ensure alignment on key projects, shared metrics, and go-to-market initiatives.
- Identify bottlenecks and streamline workflows across the commercial lifecycle—improving how we qualify, close, and manage accounts.
- Serve as a Salesforce administrator, managing system configuration, customizations, reporting, dashboards, and integrations to support evolving business needs.
- Build and maintain KPIs, reports, and dashboards to equip leadership with actionable insights and foster data-driven decision making.
- Implement and maintain processes that balance speed with accuracy, ensuring data integrity and financial alignment.
- Provide training and documentation to commercial teams on processes, systems, and best practices.
- Strong Salesforce administration skills (Salesforce Administrator certification)
Hinge Health runs a digital clinic for joint and muscle care, delivering physical therapy through a mobile app and a clinical care team. Users follow personalized exercise programs, track progress, and communicate with their care team while learning about their condition. Revenue comes from partnerships with employers and health plans that cover the service, making it free for users. The platform blends clinician-guided care with technology to make physical therapy accessible and scalable beyond traditional clinics.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
San Francisco, California
Founded
2014
Simplify's Take
What believers are saying
- Migraine Care Program targets $78B employer market with 125 clients covering 2M lives already.
- Q1 2026 revenue grew 47% YoY to $182M with 85% gross margins and strong cash generation.
- Client base expanded 23% to 2,849 employers and health plans with 52% billings growth.
What critics are saying
- Client growth slowed to 23% YoY while revenue grew 47%, indicating unsustainable pricing dependency.
- Omada Health and Kaia Health directly compete for employer contracts with lower-cost integrated platforms.
- Cefaly Technology's established migraine devices threaten Enso's $78B market expansion and 2M-life program.
What makes Hinge Health unique
- Enso's hybrid form impulse therapy delivers 54.7% pain reduction versus 25.3% for placebo devices.
- Integrated digital clinic combines wearable device, exercise therapy, and expert clinician guidance in one app.
- FDA-cleared for both musculoskeletal pain and migraine using trigeminal-nerve neuromodulation technology.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Competitive compensation with meaningful equity
Medical, Dental, Vision, Disability and Life Insurance (We cover 100% of your premium and 75% for your dependents)
Flexible PTO
FSA/HSA accounts
Family & fertility benefit through Maven Clinic
401(k) match
3 months paid parental leave
Professional Development budget
Quarterly lifestyle benefit to use towards WFH equipment & fitness
Generous mental health stipend
Work from home policy
Opportunity to join a fantastically talented, diverse, and passionate team at a pivotal time in the company's lifecycle
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 1%2 year growth
↓ -1%Gabriel M.I. Mecklenburg, a director at Hinge Health, sold 50,000 Class A Common Stock shares for approximately $1.92 million on 1 April 2026, according to an SEC Form 4 filing. The shares were sold at a weighted average price of $38.46, in line with the market close price of $38.49. The transaction was executed under a Rule 10b5-1 trading plan adopted in December 2025. The sale reduced Mecklenburg's direct Class A holdings to zero, though he continues to hold 3,268,813 Class B shares, which are convertible to Class A shares. Hinge Health, a digital musculoskeletal care platform, has a market capitalisation of $3.07 billion. Shares have risen 23% over the past year but declined 15% year to date.
Hinge Health has appointed Tyler Sloat to its board of directors. Sloat currently serves as Chief Financial Officer and Chief Operating Officer at Freshworks, overseeing finance, IT, security and corporate strategy. Sloat brings nearly three decades of operational leadership in high-growth technology companies. He previously served as CFO at Zuora, guiding the company through its 2018 IPO, and held senior positions at NetApp and Siebel Systems. He has also served on the boards of Oanda Corporation and Compass Healthcare. Hinge Health, which went public on the NYSE, provides AI-powered musculoskeletal care using wearable devices and clinical expertise. The San Francisco-based company aims to improve patient outcomes whilst reducing healthcare costs for clients.
Hinge Health shares surged 15% on Wednesday after the healthcare platform beat fourth-quarter earnings expectations. The company reported earnings of $0.49 per share on sales of $170.7 million, surpassing analyst forecasts of $0.43 per share on $156.8 million in revenue. The wearable device and AI-powered health advice provider, which treats musculoskeletal conditions, posted 46% year-over-year sales growth in the quarter. Net profit increased more than 360%, whilst free cash flow rose 65% to $61.5 million. For full-year 2025, Hinge reported 51% sales growth with 80% gross margins and $179.6 million in free cash flow. The company forecasts 39% sales growth for first-quarter 2026 and 25% annual growth to approximately $737 million, with non-GAAP earnings expected to grow 29%.
Hinge Health, a digital musculoskeletal care company, reported fourth-quarter revenue of $170.7 million, up 46% year-over-year, and full-year 2025 revenue of $587.9 million, up 51%. The company achieved non-GAAP operating income of $48 million in Q4, more than doubling from $21.4 million in the prior year. For full-year 2025, Hinge Health generated $171.4 million in operating cash flow and $179.6 million in free cash flow, nearly tripling from 2024. The company added clients to reach 2,830 total, with 25 million contracted lives and nearly 783,000 members. Hinge Health provided 2026 guidance of $732 million to $742 million in revenue and $151 million to $156 million in non-GAAP operating income. The company repurchased $65 million in shares during Q4 under its $250 million buyback programme authorised in November 2025.
Hinge Health reported a 55% revenue growth in Q2 2025, reaching $139 million, surpassing Wall Street's $125 million expectation. Shares rose 18% post-IPO, with a 52% increase from the $32 IPO price. Despite a net loss of $576 million, the company achieved a non-GAAP operating income of $26.1 million. Hinge projects Q3 revenue between $141 million and $143 million and full-year 2025 revenue between $548 million and $552 million. The HingeSelect provider network aims for a 2026 launch.